Beroni Group, an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovati...
US-based Sonoma Pharmaceuticals, a global healthcare leader developing and producing patented Microcyn technology based ...
The Japanese Ministry of Health, Labor, and Welfare (MHLW) has granted marketing authorisation for Xenpozyme (olipu...
Brii Biosciences has announced that TSB Therapeutics (Beijing), a joint venture majority-owned by the company, is p...
Daiichi Sankyo Company has obtained approval in Japan to change the indication of the analgesic 'Tarlige Tablets' (mirog...
South Korea's Daewoong Pharmaceutical has submitted the New Drug Application (NDA) for a new drug Fexuclue 40 mg Film-co...
Australians with cystic fibrosis will soon have access to a new treatment following the listing of Trikafta® on the ...
Exothera, a CDMO specialised in the development and manufacture of viral vectors for vaccines and gene therapies, receiv...
Japan-based Elix, Inc., an AI drug discovery company, has commenced joint research on the retrosynthetic analysis module...
Lotus Pharmaceuticals has acquired trademark, marketing authorization, and manufacturing know-how of Tadalafil 2.5mg, 5m...
CTT Pharmaceutical Holdings has expanded its reach into additional international markets with a successful patent applic...
Servatus Ltd, an Australian biopharmaceutical company delivering leading novel autoimmune and microbiome therapies, has ...
Arum Therapeutics, a leading pharmaceutical company that specializes in the discovery of new molecules and molecule comb...
Transcenta Holding Limited, a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, ...
China-based Zai Lab Limited has announced the appointment of Josh Smiley as its Chief Operating Officer (COO). Smiley br...
Triastek, Inc. and Siemens Ltd., China have signed a strategic collaboration agreement to provide digital tech...
Australia-based Aspen Pharmacare has announced the Therapeutic Goods Administration (TGA) listing of a new medicati...
Fujifilm Toyama Chemical Co. has announced a pause in enrollment, as of the end of March, in the currently ongoing phase...
PerkinElmer has made a number of acquisitions in life sciences and diagnostics as well as R&D investments with accel...
OBI Pharma, Inc. (OBI), a Taiwan biopharma company, and Odeon Therapeutics (Odeon), a China biopharma company, have ente...
Asieris Pharmaceuticals, a global innovative biopharma company specializing in discovering and developing innovativ...
Singapore's Health Sciences Authority (HSA) becomes the first National Regulatory Authority (NRA) to achieve M...
Antengene Corporation, a leading innovative commercial stage global biopharmaceutical company dedicated to discovering, ...
Eisai Co., Ltd. announced that LENVIMA® (generic name: lenvatinib mesylate), the multiple receptor tyrosine kinase i...
Japanese firm Shionogi has completed the analysis of primary endpoints in the Phase 2b part of a Phase 2/3 clinical...
